Tag: Multiple Sclerosis
AAN: Mediterranean Diet Score Linked to Cognition in MS
Higher MEDAS score independently predicted lower risk for cognitive impairment; link stronger for those with progressive disease
Evidence Found of Causal Link for Multisite Chronic Pain and MS, RA
Association with multiple sclerosis and rheumatoid arthritis may be partially mediated by body mass index
Neighborhood Socioeconomic Status Tied to Mortality for Neurologic Conditions
Increased odds of 30-day mortality ranges from 2.46 to 1.23 for nontraumatic coma and stroke
Adolescent Sleep Patterns Tied to Later Multiple Sclerosis Risk
Sleeping less than seven hours per night and self-reported low sleep quality during adolescence associated with risk for developing MS
Aberrations Identified in Gut Microbiota of Multiple Sclerosis Patients
Cluster of inflammation markers positively associated with multiple sclerosis-related species
Autologous Hematopoietic Stem Cell Transplant Slows Disability Progression in MS
Slowing of disability progression and higher likelihood of disability improvement observed compared with standard disease-modifying therapies
Links Explored Between Antidiabetic Meds, Multiple Sclerosis Risk
Association between exposure to antihyperglycemic medications for type 2 diabetes and risk for developing multiple sclerosis differs according to age and sex
Obesity Linked to Greater Disability, Poorer Outcomes in MS
Patients with obesity had significantly increased risk for reaching EDSS 3 over six years, independent of disease-modifying therapies
Treatments Compared for Pediatric-Onset Multiple Sclerosis
More pediatric patients free of new or newly enlarging T2 lesions at week 96 with dimethyl fumarate versus interferon beta-1a
Ublituximab Bests Teriflunomide in Relapsing Multiple Sclerosis
About 48 percent of participants receiving ublituximab had infusion-related reactions
